Stayble Therapeutics' Andreas Gerward on Capital Raise, New Ownership, and Near-Term Milestones | Andreas Gerward, CEO, Stayble Therapeutic AB. 00:10:00
Andreas has during the last 10 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
